LoadingLoadingLoadingNet selling: insiders sold $4.7M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full results8 funds hold a position and insiders have been net selling.
Buys/Adds (1)
Citadel
$54.7M
added
Sells/Trims (2)
Millennium
$24.8M
trimmed
Balyasny
$24.3M
trimmed
Top-trader positions in AXGN could not be loaded.
Hyperliquid positioning - not every stock is covered
Last report
Jul 29, 2026
Period ending
Jun 30, 2026
Earnings per share
-$0.04 expected
Revenue
Financial statements: Alpha Vantage
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 29, 2026 | -$0.03 / -$0.04Alpha Vantage | +$0.01 beat | $69.7M No estimate | Unavailable |
| Mar 31, 2026 | Apr 28, 2026 | $0.07 / $0.07Alpha Vantage | +$0.00 in line | $61.5M No estimate | Unavailable |
| Dec 31, 2025 | Feb 24, 2026 | $0.07 / $0.06Alpha Vantage | +$0.01 beat | $59.9M No estimate | Unavailable |
| Sep 30, 2025 | Oct 29, 2025 | $0.12 / $0.07Alpha Vantage | +$0.05 beat | $60.1M No estimate | Unavailable |
| Jun 30, 2025 | Aug 5, 2025 | $0.12 / $0.06Alpha Vantage | +$0.06 beat | $56.7M No estimate | Unavailable |
| Mar 31, 2025 | May 8, 2025 | -$0.02 / $0.02Alpha Vantage | -$0.04 miss | $48.6M No estimate | Unavailable |
| Dec 31, 2024 | Feb 25, 2025 | $0.07 / $0.03Alpha Vantage | +$0.04 beat | $49.4M No estimate | Unavailable |
| Sep 30, 2024 | Nov 7, 2024 | $0.07 / $0.02Alpha Vantage | +$0.05 beat | $48.6M No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $60.1M | $59.9M | $61.5M | $69.7M |
| Cost of what it sold | $14.1M | $15.5M | $15.3M | $19.1M |
| Gross profit | $46.0M | $44.4M | $46.2M | $50.7M |
| What it spent | ||||
| Research and development | $7.6M | $12.4M | $7.5M | $8.6M |
| Sales and admin | $10.8M | $14.6M | $12.9M | $13.4M |
| Other operating costs | $25.7M | $27.2M | $28.6M | $30.8M |
| Total operating expenses | $44.1M | $54.2M | $49.0M | $52.8M |
| What was left | ||||
| Operating profit | $1.9M | -$9.8M | -$2.8M | -$2.2M |
| Interest on debt | $10.2M | $1.7M | $694.0K | $1.0K |
| Profit before tax | $708.0K | -$13.2M | -$19.6M | -$1.5M |
| Net profit | $708.0K | -$13.2M | -$19.6M | -$1.5M |
| EBITDA | $12.8M | -$8.5M | -$16.8M | -$4.0K |
This stock is under pressure.
Trend
Under pressure
15 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
